Kala Bio Inc. has announced the successful settlement of its debt obligations with Oxford Finance, LLC. By making a $2 million payment, the company has fully satisfied and discharged approximately $10.6 million in debt as of December 26, 2025. This resolution eliminates a significant financial overhang, enhancing the company’s strategic flexibility and strengthening its stockholders' equity. The settlement follows a previously disclosed agreement related to events of default under a prior loan arrangement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9620162-en) on January 05, 2026, and is solely responsible for the information contained therein.
Comments